Benzinga's Top Initiations
July 15, 2013 at 07:43 AM EDT
Analysts at Credit Suisse initiated coverage on shares of PTC Therapeutics (NASDAQ: PTCT ) with an “outperform” rating. The target price for PTC Therapeutics is set to $24. PTC Therapeutics' shares closed at $16.94 on Friday. Bank of America initiated coverage on shares of Hannon Armstrong Sustainable Infrastructure Capital
